A Randomized Controlled Study on the Treatment of Cirrhosis Combined With Hypersplenism
NCT05055713 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 368
Last updated 2022-03-02
Summary
The purpose of this study was to compare the effects of partial splenic artery embolization combined with endoscopic treatment and endoscopic treatment alone on portal hypertension in cirrhosis with hyperplenism or splenomegaly in esophageal and gastric varices.
Conditions
- Liver Cirrhosis
- Esophageal and Gastric Varices
- Hypersplenism
Interventions
- PROCEDURE
-
Endoscopic therapy+ beta blockers
Endoscopic variceal ligation (EVL) is for the secondary prophylaxis of esophageal variceal hemorrhage,and Cyanoacrylate injection is for gastric varices (GV).A standard dose of NSBB (carvedilol) was applied to patients according to the Baveno VI recommendations if there were no contraindications.
- PROCEDURE
-
Endoscopic therapy+ PSE+beta blockers
Endoscopic variceal ligation (EVL) is for the secondary prophylaxis of esophageal variceal hemorrhage,and Cyanoacrylate injection is for gastric varices (GV).A standard dose of NSBB (carvedilol) was applied to patients according to the Baveno VI recommendations if there were no contraindications.Partial splenic embolization (PSE) is one of the intra-arterial therapeutic approaches to embolize 60-80% splenic blood flow.
- PROCEDURE
-
Endoscopic therapy
Endoscopic variceal ligation (EVL) is for the secondary prophylaxis of esophageal variceal hemorrhage,and Cyanoacrylate injection is for gastric varices (GV).
- PROCEDURE
-
Endoscopic therapy+ PSE
Endoscopic variceal ligation (EVL) is for the secondary prophylaxis of esophageal variceal hemorrhage,and Cyanoacrylate injection is for gastric varices (GV).Partial splenic embolization (PSE) is one of the intra-arterial therapeutic approaches to embolize 60-80% splenic blood flow.
- PROCEDURE
-
Endoscopic therapy+Somatostatin
The first dose of 250 was injected intravenously, followed by a continuous iv infusion of 250 for 3-5 days. Endoscopic variceal ligation (EVL) is for the acute bleeding of esophageal variceal hemorrhage,and Cyanoacrylate injection is for gastric varices (GV).
- PROCEDURE
-
Endoscopic therapy+PSE+Somatostatin
The first dose of 250 was injected intravenously, followed by a continuous iv infusion of 250 for 3-5 days. Endoscopic variceal ligation (EVL) is for the acute bleeding of esophageal variceal hemorrhage,and Cyanoacrylate injection is for gastric varices (GV).Partial splenic embolization (PSE) is one of the intra-arterial therapeutic approaches to embolize 60-80% splenic blood flow.
Sponsors & Collaborators
-
Qilu Hospital of Shandong University
lead OTHER
Principal Investigators
-
Yanjing Gao, PhD.MD · Qilu Hospital, Shandong University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-25
- Primary Completion
- 2022-12-31
- Completion
- 2022-12-31
Countries
- China
Study Locations
More Related Trials
-
Effects of Somatostatin on Post-endoscopic Portal Hemodynamic in Cirrhotic Patients With Esophageal Gastric Varices
NCT01426087 ·Status: UNKNOWN ·Phase: NA
-
EUS-guided PSE in Combination With EUS-guided Treatment of Varices for Patients With Portal Hypertension
NCT04692805 ·Status: UNKNOWN ·Phase: NA
-
Effect of Re-education on Rebleeding Rate After Endoscopic Treatment in Liver Cirrhosis
NCT05302661 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Early Enteral Nutrition on Endoscopic Therapy of Esophagogastric Varices in Liver Cirrhosis
NCT04823780 ·Status: COMPLETED
-
Percutaneous Transhepatic Intrahepatic Portosystemic Shunt for Treatment of Portal Vein Occlusion With Symptomatic Portal Hypertension After Splenectomy
NCT02505152 ·Status: UNKNOWN ·Phase: NA
-
Preemptive TIPS for Gastric Variceal Bleeding in Patients With Cirrhosis
NCT06122792 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV
NCT02853526 ·Status: UNKNOWN ·Phase: PHASE3
-
The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis:A Multicenter RCT
NCT02630095 ·Status: UNKNOWN ·Phase: PHASE4
-
The Timing of Emergency Endoscopy for Esophagogastric Variceal Bleeding in Cirrhosis
NCT04932200 ·Status: UNKNOWN
-
Preemptive TIPS for Variceal Bleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis
NCT06122753 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
TIPS for Complicated Portal Hypertension Related to Porto-Sinusoidal Vascular Disease
NCT07163689 ·Status: RECRUITING
-
The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy
NCT04221672 ·Status: UNKNOWN ·Phase: PHASE3
-
Laparoscopic Versus Open Devascularization for Portal Hypertension, a Randomized Controlled Trial
NCT02178319 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Endoscopic Variceal Ligation (EVL) Versus EVL Plus Non-selective B-blockers (NSBB) For Prevention of Variceal Rebleed and Non-bleed Related Complications in Patients With Advanced Cirrhosis
NCT02739581 ·Status: WITHDRAWN ·Phase: NA
-
Timing of Endoscopy for Acute Variceal Bleeding in Patients With Cirrhosis
NCT04957875 ·Status: COMPLETED
-
Mechanism of TIPS to Improve Sarcopenia
NCT06794853 ·Status: RECRUITING
-
Evaluation of Endoscopic Treatment Effect Based on HVPG
NCT06863519 ·Status: ENROLLING_BY_INVITATION
-
Early Use of TIPSS in Patients With Cirrhosis and Variceal Bleeding
NCT02377141 ·Status: COMPLETED ·Phase: NA
-
Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis
NCT01326949 ·Status: COMPLETED ·Phase: NA
-
Early Precise Diagnosis and Intervention of CPT Based on a Noninvasive 3D-vHPS
NCT02925975 ·Status: UNKNOWN ·Phase: PHASE4
-
Portal Vein Thrombosis in Cirrhosis
NCT02275585 ·Status: WITHDRAWN
-
Embolization of Large Spontaneous Portosystemic Shunts for the Prevention of Post-TIPS Hepatic Encephalopathy
NCT02156232 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Methods and Surgical Risk Stratification in Cirrhotics Undergoing Elective Extrahepatic Surgery
NCT04615091 ·Status: UNKNOWN
-
WFA+M2BP in Evaluation of Portal Hypertension and Clinical Outcome in Patients With Liver Cirrhosis
NCT03195634 ·Status: UNKNOWN
-
Impact of Nonselective Beta-blocker on Acute Kidney Injury in Cirrhotic Patients With Esophageal Varices
NCT04074473 ·Status: UNKNOWN ·Phase: PHASE4